{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Bortezomib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Bortezomib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Bortezomib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "bortezomib",
    "trial_2_text": "Bortezomib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Bortezomib Supplement: 60 participants will take Bortezomib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Bortezomib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Bortezomib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.37810078263282776,
      "17": 0.25068399310112,
      "177": 0.22567541897296906,
      "20": 0.20403246581554413,
      "123": 0.20238976180553436,
      "9": 0.18838290870189667,
      "78": 0.1876579076051712,
      "21": 0.18594014644622803,
      "2": 0.17721691727638245,
      "64": 0.1673847734928131,
      "173": 0.1673765331506729,
      "37": 0.1637469232082367,
      "77": 0.15793436765670776,
      "67": 0.1456785649061203,
      "14": 0.13804693520069122,
      "68": 0.1366964727640152,
      "114": 0.1274159699678421,
      "200": 0.12476960569620132,
      "228": 0.12005066126585007,
      "49": 0.11568765342235565,
      "101": 0.11368619650602341,
      "243": 0.11240045726299286,
      "46": 0.10771878063678741,
      "126": 0.1066088005900383,
      "29": 0.10556817054748535,
      "85": 0.10435855388641357,
      "79": 0.10415751487016678,
      "189": 0.10354997962713242,
      "239": 0.09782463312149048,
      "144": 0.09599409997463226,
      "350": 0.09366974234580994,
      "194": 0.09351259469985962,
      "179": 0.09176673740148544,
      "122": 0.08915127068758011,
      "188": 0.0878329947590828,
      "180": 0.08703822642564774,
      "133": 0.08620493113994598,
      "72": 0.08534271270036697,
      "86": 0.08295418322086334,
      "76": 0.08286382257938385,
      "28": 0.08211902529001236,
      "193": 0.07994486391544342,
      "142": 0.0789857879281044,
      "154": 0.07782124727964401,
      "1": 0.0767221450805664,
      "104": 0.07543062418699265,
      "288": 0.0713401660323143,
      "27": 0.06999241560697556,
      "82": 0.06910956650972366,
      "61": 0.06895432621240616,
      "355": 0.06842649728059769,
      "121": 0.06686621904373169,
      "96": 0.06576497107744217,
      "36": 0.06443382054567337,
      "35": 0.06224768981337547,
      "18": 0.06197423115372658,
      "170": 0.06082550436258316,
      "249": 0.06062622368335724,
      "69": 0.05998802185058594,
      "139": 0.057540856301784515,
      "234": 0.057470351457595825,
      "38": 0.05716654658317566,
      "102": 0.05639776960015297,
      "261": 0.056280817836523056,
      "131": 0.05517594888806343,
      "116": 0.05505795404314995,
      "212": 0.05278594046831131,
      "135": 0.05197136849164963,
      "5": 0.051926665008068085,
      "130": 0.0518876276910305,
      "147": 0.05142340436577797,
      "100": 0.05085178092122078,
      "186": 0.050722673535346985,
      "282": 0.050088103860616684,
      "30": 0.04985671117901802,
      "361": 0.04939546808600426,
      "136": 0.04858505353331566,
      "89": 0.048480141907930374,
      "221": 0.04792068898677826,
      "254": 0.04748905077576637,
      "195": 0.04704183340072632,
      "396": 0.046883828938007355,
      "92": 0.04663161188364029,
      "151": 0.04636525735259056,
      "246": 0.04616191238164902,
      "253": 0.045510780066251755,
      "132": 0.04514152184128761,
      "22": 0.04482361301779747,
      "204": 0.0446726493537426,
      "356": 0.0439949706196785,
      "256": 0.043985120952129364,
      "211": 0.04392533749341965,
      "441": 0.04348580539226532,
      "218": 0.04323938488960266,
      "286": 0.04218928515911102,
      "269": 0.04188093915581703,
      "98": 0.04148656502366066,
      "213": 0.04126047343015671,
      "164": 0.041186731308698654,
      "242": 0.04104839265346527
    },
    "trial_2_ae": {
      "87": 0.37810078263282776,
      "17": 0.25068399310112,
      "177": 0.22567541897296906,
      "20": 0.20403246581554413,
      "123": 0.20238976180553436,
      "9": 0.18838290870189667,
      "78": 0.1876579076051712,
      "21": 0.18594014644622803,
      "2": 0.17721691727638245,
      "64": 0.1673847734928131,
      "173": 0.1673765331506729,
      "37": 0.1637469232082367,
      "77": 0.15793436765670776,
      "67": 0.1456785649061203,
      "14": 0.13804693520069122,
      "68": 0.1366964727640152,
      "114": 0.1274159699678421,
      "200": 0.12476960569620132,
      "228": 0.12005066126585007,
      "49": 0.11568765342235565,
      "101": 0.11368619650602341,
      "243": 0.11240045726299286,
      "46": 0.10771878063678741,
      "126": 0.1066088005900383,
      "29": 0.10556817054748535,
      "85": 0.10435855388641357,
      "79": 0.10415751487016678,
      "189": 0.10354997962713242,
      "239": 0.09782463312149048,
      "144": 0.09599409997463226,
      "350": 0.09366974234580994,
      "194": 0.09351259469985962,
      "179": 0.09176673740148544,
      "122": 0.08915127068758011,
      "188": 0.0878329947590828,
      "180": 0.08703822642564774,
      "133": 0.08620493113994598,
      "72": 0.08534271270036697,
      "86": 0.08295418322086334,
      "76": 0.08286382257938385,
      "28": 0.08211902529001236,
      "193": 0.07994486391544342,
      "142": 0.0789857879281044,
      "154": 0.07782124727964401,
      "1": 0.0767221450805664,
      "104": 0.07543062418699265,
      "288": 0.0713401660323143,
      "27": 0.06999241560697556,
      "82": 0.06910956650972366,
      "61": 0.06895432621240616,
      "355": 0.06842649728059769,
      "121": 0.06686621904373169,
      "96": 0.06576497107744217,
      "36": 0.06443382054567337,
      "35": 0.06224768981337547,
      "18": 0.06197423115372658,
      "170": 0.06082550436258316,
      "249": 0.06062622368335724,
      "69": 0.05998802185058594,
      "139": 0.057540856301784515,
      "234": 0.057470351457595825,
      "38": 0.05716654658317566,
      "102": 0.05639776960015297,
      "261": 0.056280817836523056,
      "131": 0.05517594888806343,
      "116": 0.05505795404314995,
      "212": 0.05278594046831131,
      "135": 0.05197136849164963,
      "5": 0.051926665008068085,
      "130": 0.0518876276910305,
      "147": 0.05142340436577797,
      "100": 0.05085178092122078,
      "186": 0.050722673535346985,
      "282": 0.050088103860616684,
      "30": 0.04985671117901802,
      "361": 0.04939546808600426,
      "136": 0.04858505353331566,
      "89": 0.048480141907930374,
      "221": 0.04792068898677826,
      "254": 0.04748905077576637,
      "195": 0.04704183340072632,
      "396": 0.046883828938007355,
      "92": 0.04663161188364029,
      "151": 0.04636525735259056,
      "246": 0.04616191238164902,
      "253": 0.045510780066251755,
      "132": 0.04514152184128761,
      "22": 0.04482361301779747,
      "204": 0.0446726493537426,
      "356": 0.0439949706196785,
      "256": 0.043985120952129364,
      "211": 0.04392533749341965,
      "441": 0.04348580539226532,
      "218": 0.04323938488960266,
      "286": 0.04218928515911102,
      "269": 0.04188093915581703,
      "98": 0.04148656502366066,
      "213": 0.04126047343015671,
      "164": 0.041186731308698654,
      "242": 0.04104839265346527
    }
  },
  "safety": {
    "trial_1_safety": 0.3711583912372589,
    "trial_2_safety": 0.3711583912372589
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4772424101829529
  }
}